Published in Neuroscience on April 01, 1984
Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am J Pathol (2000) 1.26
Desensitization of the neurokinin-1 receptor (NK1-R) in neurons: effects of substance P on the distribution of NK1-R, Galphaq/11, G-protein receptor kinase-2/3, and beta-arrestin-1/2. Mol Biol Cell (1998) 1.24
High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes. Cell Tissue Res (2013) 0.92
Tachykinin NK1 but not NK2 receptors mediate non-cholinergic excitatory junction potentials in the circular muscle of guinea-pig colon. Br J Pharmacol (1993) 0.91
Tachykininergic transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of NK2 receptors. Br J Pharmacol (1992) 0.87
Release of dynorphin, somatostatin and substance P from the vascularly perfused small intestine of the guinea-pig during peristalsis. Br J Pharmacol (1984) 0.86
Inhibition of nitric oxide synthesis reveals non-cholinergic excitatory neurotransmission in the canine proximal colon. Br J Pharmacol (1993) 0.86
The actions of two sensory neuropeptides, substance P and calcitonin gene-related peptide, on the canine hepatic arterial and portal vascular beds. Br J Pharmacol (1992) 0.82
Effect of opioid peptides on circular muscle of canine duodenum. J Physiol (1991) 0.80
Substance P is essential for maintaining gut muscle contractility: a novel role for coneurotransmission revealed by botulinum toxin. Am J Physiol Gastrointest Liver Physiol (2014) 0.77
Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol (1979) 3.80
Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol (1980) 2.54
Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg (1989) 1.89
Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.85
Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear. Naunyn Schmiedebergs Arch Pharmacol (1974) 1.74
Search for a physiological role of substance P in gastrointestinal motility. Neuroscience (1985) 1.64
Release of histamine by substance P. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.56
Substance P release from spinal cord slices by capsaicin. Life Sci (1979) 1.49
Low potential of dobutamine and dopexamine to block intestinal peristalsis as compared with other catecholamines. Crit Care Med (2000) 1.41
The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol (1992) 1.36
Substance P in peripheral sensory processes. Ciba Found Symp (1982) 1.28
Capsaicin applied to peripheral nerve inhibits axoplasmic transport of substance P and somatostatin. Brain Res (1982) 1.28
The molecular weights of plasma and intestinal kallikreins in rats. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.27
The effect of capsaicin application to a peripheral nerve on impulse conduction in functionally identified afferent nerve fibres. Brain Res (1983) 1.27
Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci (1983) 1.26
Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venoconstriction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit. Br J Pharmacol (1987) 1.25
Neurally mediated contraction of ileal longitudinal muscle by substance P. Neurosci Lett (1980) 1.25
Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide. Eur J Pharmacol (1982) 1.24
Substance P in the vagus nerve. Immunochemical and immunohistochemical evidence for axoplasmic transport. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.23
Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology (1986) 1.21
Endoscopic neurosurgery. Acta Neurochir (Wien) (1988) 1.21
Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur Respir J (1994) 1.21
Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci U S A (1986) 1.20
Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.17
Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol (1992) 1.15
Inhibition of stimulated fluid secretion in the rat small and large intestine by opiate agonists. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.13
Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.12
Analysis of the effects of intravenously injected capsaicin in the rat. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.12
Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.08
Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation. Br J Pharmacol (1989) 1.07
Capsaicin-sensitive non-cholinergic excitatory innervation of the guinea-pig tracheobronchial smooth muscle. Neurosci Lett (1982) 1.07
Evidence for the involvement of substance P in the atropine-resistant peristalsis of the guinea-pig ileum. Neurosci Lett (1982) 1.06
Opioid control of the function of primary afferent substance P fibres. Eur J Pharmacol (1985) 1.06
Intragastric capsaicin enhances rat gastric acid elimination and mucosal blood flow by afferent nerve stimulation. Br J Pharmacol (1989) 1.06
Postocclusive cutaneous vasodilatation mediated by substance P. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.05
Opiate agonists inhibit neurogenic plasma extravasation in the rat. Eur J Pharmacol (1981) 1.03
Elimination of substance P from the circulation of the rat and its inhibition by bacitracin. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.02
Cannabinoid inhibition of guinea-pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways. Neuropharmacology (1999) 1.01
Chemical characterization and regulation of endogenous morphine and codeine in the rat. J Pharmacol Exp Ther (1987) 1.01
Characterization of the stimulus-induced release of immunoreactive substance P from the myenteric plexus of the guinea-pig small intestine. Brain Res (1984) 1.00
Ruthenium red selectively prevents capsaicin-induced nociceptor stimulation. Eur J Pharmacol (1989) 0.99
Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br J Pharmacol (1992) 0.98
Bradykinin-induced sensitization of afferent neurons in the rat paw. Neuroscience (1994) 0.98
Gastric acid-evoked c-fos messenger RNA expression in rat brainstem is signaled by capsaicin-resistant vagal afferents. Gastroenterology (1998) 0.98
New type of nerve-mediated cholinergic contractions of the guinea-pig small intestine and its selective blockade by capsaicin. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.98
Requirement of nerve growth factor for development of substance P-containing sensory neurones. Nature (1980) 0.98
Tachykinin NK1 and NK2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro. Neuropharmacology (1998) 0.98
Activity of SR 142801 at peripheral tachykinin receptors. Eur J Pharmacol (1995) 0.97
Effect of neuropeptides on the efficiency of the peristaltic reflex. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.97
Neuropeptide Y inhibits excitatory enteric neurons supplying the circular muscle of the guinea pig small intestine. Gastroenterology (1987) 0.96
Evidence that the contractile response of the guinea-pig ileum to capsaicin is due to release of substance P. J Physiol (1982) 0.96
Nociceptor stimulation and PGE release by capsaicin. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.96
[Substance P and salivary secretion]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.95
Regional differences in the response to substance P on the longitudinal muscle and the concentration of substance P in the digestive tract of the guinea-pig. Neuroscience (1981) 0.95
Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine and oesophagus. Neuroscience (1999) 0.95
Indirect evidence for the inhibition of enteric substance P neurones by opiate agonists but not by capsaicin. Eur J Pharmacol (1982) 0.95
Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br J Pharmacol (1994) 0.95
Interaction of prostaglandins and indomethacin with algesic substances. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.95
Different receptors mediating the inhibitory action of exogenous ATP and endogenously released purines on guinea-pig intestinal peristalsis. Br J Pharmacol (1999) 0.94
Capsaicin-sensitive vagal afferents contribute to gastric acid and vascular responses to intracisternal TRH analog. Peptides (1990) 0.94
Distribution of capsaicin-sensitive nerve fibres containing immunoreactive substance P in cutaneous and visceral tissues of the rat. Neurosci Lett (1982) 0.94
Pathological events in experimental acute pancreatitis prevented by the bradykinin antagonist, Hoe 140. Br J Pharmacol (1993) 0.94
Caerulein, substance P, serotonin and cholinomimetics induce rhythmic contractions of the intestinal circular muscle. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.94
Visceral pain reflex after pretreatment with capsaicin and morphine. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.94
Inhibition by morphine of prostaglandin E1-stimulated secretion and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum in vivo. Br J Pharmacol (1980) 0.94
Analgesic effect of antagonists of substance P. Biochem Biophys Res Commun (1981) 0.94
Distribution of capsaicin in rat tissues after systemic administration. J Pharm Pharmacol (1982) 0.93
Capsaicin-induced stimulation of polymodal nociceptors is antagonized by ruthenium red independently of extracellular calcium. Neuroscience (1989) 0.93
Inhibition of gastrointestinal transit due to surgical trauma or peritoneal irritation is reduced in capsaicin-treated rats. Gastroenterology (1986) 0.93
Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience (2007) 0.93
Selective ablation of spinal afferent neurons containing CGRP attenuates gastric hyperemic response to acid. Peptides (1992) 0.93
Nitric oxide mediates the amplification by interleukin-1 beta of neurogenic vasodilatation in the rat skin. Eur J Pharmacol (1994) 0.93
In vitro release of endogenous catecholamines from the neural and intermediate lobe of the hypophysis. Neuroendocrinology (1982) 0.92